Invention Grant
- Patent Title: Substituted imidazoquinoxalines
- Patent Title (中): 取代的咪唑并喹啉
-
Application No.: US13264627Application Date: 2010-04-24
-
Publication No.: US08729082B2Publication Date: 2014-05-20
- Inventor: Marcus Koppitz , Benjamin Bader , Ulf Bömer , Bertolt Kreft , Philip Lienau , Tobias Marquardt , Stefan Prechtl , Gerhard Siemeister , Christof Wegscheid-Gerlach
- Applicant: Marcus Koppitz , Benjamin Bader , Ulf Bömer , Bertolt Kreft , Philip Lienau , Tobias Marquardt , Stefan Prechtl , Gerhard Siemeister , Christof Wegscheid-Gerlach
- Applicant Address: DE Monheim
- Assignee: Bayer Intellectual Property GmbH
- Current Assignee: Bayer Intellectual Property GmbH
- Current Assignee Address: DE Monheim
- Priority: EP09159045 20090429
- International Application: PCT/EP2010/002543 WO 20100424
- International Announcement: WO2010/124826 WO 20101104
- Main IPC: A61K31/4985
- IPC: A61K31/4985 ; A61K31/5377 ; C07D487/04
Abstract:
The present invention relates to substituted imidazoquinoxaline compounds of general formula (I) as inhibitors of Mps-1 Kinase or TTK, and being active against inflammation and cancer.
Public/Granted literature
- US20120128662A1 SUBSTITUTED IMIDAZOQUINOXALINES Public/Granted day:2012-05-24
Information query
IPC分类:
